Kaplan-Meier survival analyses demonstrated that, compared with HCC patients without CCT7 alterations, HCC patients with CCT7 alterations had poorer OS (P = 6.568e-03, Figure 7C), disease-free survival (P = 5.715e-03, Figure 7D), progression-free survival (P = 2.150e-02, Figure 7E) and disease-specific survival (P = 4.0e-02, Figure 7F). This evidence concerns the gene CCT7 and hepatocellular carcinoma.